Phase I/II clinical and pharmacokinetic study of ecubectedin in combination with irinotecan in patients with selected advanced solid tumors

被引：0
|
作者：
Torralvo, A. Gil [1 ]
Vieito, M. [2 ]
Martinez Perez, J. [1 ]
Pretelli, G. [2 ]
Martinez, V. [3 ]
Boggio, G. F. [4 ]
Fernandez, C. M. [4 ]
Hernandez, A. [4 ]
Cristoveanu, E. [4 ]
Belgrano, A. [4 ]
Kahatt, C. [4 ]
Fudio, S. [4 ]
Nieto, A. [4 ]
Redondo, A. [3 ]
机构：
[1] Hosp Univ Virgen Rocio, Oncol, Seville, Spain
[2] VHIO Vall dHebron Inst Oncol, Oncol, Barcelona, Spain
[3] Hosp Univ La Paz, Dept Oncol Med, Madrid, Spain
[4] PharmaMar SA, Clinical, Colmenar Viejo, Spain
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.708
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
641P
引用
收藏
页码：S508 / S508
页数：1
相关论文
共 50 条
  • [41] Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors
    Saltz, LB
    Spriggs, D
    Schaaf, LJ
    Schwartz, GK
    Ilson, D
    Kemeny, N
    Kanowitz, J
    Steger, C
    Eng, M
    Albanese, P
    Semple, D
    Hanover, CK
    Elfring, GL
    Miller, LL
    Kelsen, D
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) : 3858 - 3865
  • [42] Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors
    Erich Brendel
    Matthias Ludwig
    Chetan Lathia
    Caroline Robert
    Stanislas Ropert
    Jean-Charles Soria
    Jean-Pierre Armand
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 53 - 61
  • [43] Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors
    Brendel, Erich
    Ludwig, Matthias
    Lathia, Chetan
    Robert, Caroline
    Ropert, Stanislas
    Soria, Jean-Charles
    Armand, Jean-Pierre
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (01) : 53 - 61
  • [44] Phase I/II study of ISIS 183750 in combination with irinotecan for advanced solid tumors or colorectal cancer: Final results.
    Makarova-Rusher, Oxana V.
    Duffy, Austin G.
    Ulahannan, Susanna Varkey
    Fioravanti, Suzanne
    Walker, Melissa
    Raffeld, Mark
    Compton, Kathryn
    Lee, Sunmin
    Tomita, Yusuke
    Trepel, Jane B.
    Figg, William Douglas
    Greten, Tim F.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [45] Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors
    Korfel, A
    Scheulen, ME
    Schmoll, HJ
    Grundel, O
    Harstrick, A
    Knoche, M
    Fels, LM
    Skorzec, M
    Bach, F
    Baumgart, J
    Sass, G
    Seeber, S
    Thiel, E
    Berdel, WE
    CLINICAL CANCER RESEARCH, 1998, 4 (11) : 2701 - 2708
  • [46] Phase I and pharmacokinetic study of irinotecan in combination with raltitrexed
    Lewis, NL
    Scher, R
    Gallo, JM
    Engstrom, PF
    Szarka, CE
    Litwin, S
    Adams, AL
    Kilpatrick, D
    Brady, D
    Weiner, LM
    Meropol, NJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (04) : 257 - 265
  • [47] Mogamulizumab in Combination with Nivolumab in a Phase I/II Study of Patients with Locally Advanced or Metastatic Solid Tumors
    Hong, David S.
    Rixe, Olivier
    Chiu, Vi K.
    Forde, Patrick M.
    Dragovich, Tomislav
    Lou, Yanyan
    Nayak-Kapoor, Asha
    Leidner, Rom
    Atkins, James N.
    Collaku, Agron
    Fox, Floyd E.
    Marshall, Margaret A.
    Olszanski, Anthony J.
    CLINICAL CANCER RESEARCH, 2022, 28 (03) : 479 - 488
  • [48] Phase I and pharmacokinetic study of irinotecan in combination with raltitrexed
    Nancy L. Lewis
    Richard Scher
    James M. Gallo
    Paul F. Engstrom
    Christine E. Szarka
    Samuel Litwin
    Andrea L. Adams
    Deborah Kilpatrick
    Diane Brady
    Louis M. Weiner
    Neal J. Meropol
    Cancer Chemotherapy and Pharmacology, 2002, 50 : 257 - 265
  • [49] Phase I clinical and pharmacokinetic study of combination chemotherapy with topotecan and ifosfamide in patients with progressive or relapsed solid tumors
    Schneider, CP
    Merkel, U
    Grübner, U
    Kath, R
    Höffken, K
    Hoffmann, A
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2002, 128 (06) : 313 - 318
  • [50] A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors
    Christos E. Kyriakopoulos
    Amy M. Braden
    Jill M. Kolesar
    Jens C. Eickhoff
    Howard H. Bailey
    Jennifer Heideman
    Glenn Liu
    Kari B. Wisinski
    Investigational New Drugs, 2017, 35 : 290 - 297
12345